Feb 09, 2017 21:08 pm UTC| Business
CORAL GABLES, Fla., Feb. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
Web.com Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 09, 2017 21:07 pm UTC| Business
Solid progress on Yodle integration and strong financial performance that beat profit targets and hit the high end of revenue guidanceGenerated $128 million of operating cash flow and $106 million of free cash flow for the...
Feb 09, 2017 21:07 pm UTC| Business
CORAL GABLES, Fla., Feb. 09, 2017 -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases,...
Web.com Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 09, 2017 21:07 pm UTC| Business
Solid progress on Yodle integration and strong financial performance that beat profit targets and hit the high end of revenue guidanceGenerated $128 million of operating cash flow and $106 million of free cash flow for the...
Web.com Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 09, 2017 21:07 pm UTC| Business
Solid progress on Yodle integration and strong financial performance that beat profit targets and hit the high end of revenue guidanceGenerated $128 million of operating cash flow and $106 million of free cash flow for the...
Feb 09, 2017 21:07 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- At the end of the settlement date of January 31, 2017, short interest in 2,352 Nasdaq Global MarketSM securities totaled 7,153,961,241 shares compared with 7,113,199,016 shares in 2,355 Global...
Feb 09, 2017 21:07 pm UTC| Business
NEW YORK, Feb. 09, 2017 -- At the end of the settlement date of January 31, 2017, short interest in 2,352 Nasdaq Global MarketSM securities totaled 7,153,961,241 shares compared with 7,113,199,016 shares in 2,355 Global...